---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "R2TuR81O7UMGPpdyhhQkPkfYtImH6Hr7Eg3LqWD9E7x0HgBQSyncjuCh37iqxx6Nn8CSzPH73AWou+yj8xH2eanaLn/Q4qKShjTus7cw/9o0g04VmCKZUrgBB16n7grv2e3xTeuOXNP/KUuH2EcKE6rWLis2VfuN/KWP3AxFAghSx3BDwwJQELHPlFVQwUCwMrP0RCdcd2iGU7TsiWsDp0w0pnNOLmEsGlAH5yeMSFANkmpEyRSYfMCRWpqtCWKCsLdE2kl/DSSNGfqwrBbWeGlsawdkSaGqGLDH4DMx5+8zokWA+Ukk5ujLHvu4SOvibOe3vIgesUe/QouB/yqSGA0qaFjzBhLXKNS0Hj3aSgw=;732Ax3ayMkPUpFA3F3+lCg=="
---

